Signifier Medical Technologies (SMT), is a British medical technology company, founded by two UK citizens, focused on the development and commercialisation of innovative and non-invasive solutions for patients with snoring and sleep-disordered breathing conditions. Having completed our first clinical trials in England and accelerated development with multiple Innovate UK grants, Signifier is dedicated to increasing the prominence of British medical technology innovation on the world stage. Pioneers in challenging the wisdom of conventional snoring and sleep apnoea treatments, SMT created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse. Representing a major milestone in sleep medicine, our revolutionary eXciteOSA device and therapy focuses on treating a primary root cause of OSA by strengthening upper airway musculature rather than alleviating symptoms. Its efficacy is verified in multiple published clinical studies.

SMT has sold over 5,000 units worldwide and gross invoiced sales of USD 3.2m between March and December 2021. Patients have completed over 100,000 therapies. Therapy adherence is within 84-90%. eXciteOSA therapy has been widely accepted by c. 900 physicians across the globe. The eXciteOSA Trustpilot rating is 4.5 at time of writing.

Prof. Akhil Tripathi, co-founder and CEO of SMT, is a successful British serial entrepreneur and MedTech innovator, having developed and commercialized several novel medical devices, including a robotic navigation system for neurosurgeries and a spinal implant for the cervical spine. SMT’s other co-founder is Prof. Dr. Anshul Sama, who is also a member of the SMT’s Medical Advisory Board and a core member of Nottingham Sleep Centre. He has more than 20 years of experience in sleep-disordered breathing, has established expertise and internationally recognized publications.

Products and services

Medical Device, Healthtech, Healthcare, Medtech, Sleep Apnea, eXciteOSA

Industry

Healthcare and medical, Life sciences

International

Canada, Germany, United Kingdom, United States